The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer
Open accessAbstract
The aim of the study was to investigate long‐term trends in the incidence of borderline tumors and ovarian cancer in Sweden during 1960–2005, based on data from the population‐based Swedish Cancer Register. We identified 6,288 patients with borderline ovarian tumors and a total of 34,977 cases of ovarian cancer during the study period. The age‐standardized incidence of borderline ovarian tumors increased from 1.0 to 5.3 per 100,000 women‐years from 1960–1964 to 2000–2005 and the incidence of ovarian cancer increased from 16.4 to 19.7 per 100,000 women‐years from 1960–1964 to 1980–1989 and then declined to 16.6 per 100,000 women‐years to the period 2000–2005. Borderline ovarian tumors comprised 15% of all primary ovarian neoplasms and the proportion increased from 8.3 to 23.6% during the study period. The median age at diagnosis for patients with borderline ovarian tumors and ovarian cancer was 55.2 and 61.6 years, respectively. In women younger than 40 years, 34% of all primary ovarian malignancies consisted of borderline ovarian tumors. For the 5 birth cohorts evaluated, the peaks of incidence occurred in stepwise younger age for each younger birth cohort for both borderline tumors and ovarian cancer. The increasing incidence of borderline ovarian tumors could be explained by an increase in diagnostic activity and by a lack of protective effect of oral contraceptive use. The decline in invasive tumors could be explained by a combination of factors, where the contribution of each is uncertain: shifting exposure to risk factors, a protective effect of oral contraceptive use, and increased detection of and removal of precancerous lesions. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges
Shih, I.-M., & Kurman, R. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0755 · Cited by 142
Cited by
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ: Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
Coleman, M., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., Nur, U., Tracey, E., Coory, M., Hatcher, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62231-3 · Cited by 1,114
Menon, U., Gentry-Maharaj, A., Hallett, R., Ryan, A., Burnell, M., Sharma, A., Lewis, S., Davies, S., Philpott, S., Lopes, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70026-9 · Cited by 829
Diagnosis, Treatment, and Follow-Up of Borderline Ovarian Tumors
Fischerova, D., Zikan, M., Dundr, P., & Cibula, D. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0139 · Cited by 279
MRI, CT, and PET/CT for Ovarian Cancer Detection and Adnexal Lesion Characterization
Iyer, V. R., & Lee, S. I. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.3522 · Cited by 263
Metadata
- Authors
- Skírnisdóttir, I., Garmo, H., Wilander, E., & Holmberg, L.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2008-08-13
- Volume
- 123
- Issue
- 8
- Pages
- 1897-1901
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2093650348
- Cited by
- 246
- References
- 1
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer. https://app.cochat.ai/papers/10.1002/ijc.23724
- The paper
- Skírnisdóttir, I., Garmo, H., Wilander, E., & Holmberg, L. (2008). Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.23724
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.